Drug Manufacturing

Dec 14, 2017
By Pharmaceutical Technology Editors
FDA has approved a Pfizer biosimilar to J&J’s top-selling anti-inflammatory biologic, Remicade.
Dec 14, 2017
By Pharmaceutical Technology Editors
The company is seeking approval from FDA for use of the drug, migalastat, to treat Fabry disease in patients who have amenable mutations.
Dec 13, 2017
By Pharmaceutical Technology Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
Dec 13, 2017
By Pharmaceutical Technology Editors
The companies will co-develop and co-commercialize the lead candidate generated from their earlier collaboration to treat genetic blood disorders.
Dec 13, 2017
By Pharmaceutical Technology Editors
In partnership with Indian pharmaceutical firm, Torrent Pharmaceuticals, Novo Nordisk has expanded an insulin manufacturing facility at Torrent’s Indrad, Gujarat, India site.
Dec 08, 2017
By Pharmaceutical Technology Editors
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
Dec 06, 2017
By Pharmaceutical Technology Editors
The company will expand two of its Ohio facilities, investing approximately $145 million to support manufacturing and warehouse operations.
Dec 06, 2017
By Pharmaceutical Technology Editors
A survey by LNS Research and sponsored by Honeywell showed that industrial companies are not moving quickly to adopt cyber security; calls on CEOs to take action.
Dec 05, 2017
By Pharmaceutical Technology Editors
Biopharma majors are among the industry stakeholders who have commented and raised questions about FDA’s recently proposed draft guidance for analytical assessment of similarity in biosimilars.
Dec 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The Ross, Charles & Son Ross X-Series is a clean-in-place (CIP) ready ultra-high shear mixer for inline emulsification, particle size reduction, and homogenization.
native1_300x100
lorem ipsum